Edward J. Lewis

875 total citations
5 papers, 360 citations indexed

About

Edward J. Lewis is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Edward J. Lewis has authored 5 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Cancer Research. Recurrent topics in Edward J. Lewis's work include Cell death mechanisms and regulation (3 papers), Cancer-related Molecular Pathways (2 papers) and Ubiquitin and proteasome pathways (2 papers). Edward J. Lewis is often cited by papers focused on Cell death mechanisms and regulation (3 papers), Cancer-related Molecular Pathways (2 papers) and Ubiquitin and proteasome pathways (2 papers). Edward J. Lewis collaborates with scholars based in United Kingdom. Edward J. Lewis's co-authors include John F. Lyons, Neil T. Thompson, Matthew Squires, Nicola G. Wallis, David M. Cross, Ruth E. Feltell, Donna-Michelle Smith, George A. Ward, Christopher N. Johnson and Gianni Chessari and has published in prestigious journals such as Journal of Medicinal Chemistry and Molecular Cancer Therapeutics.

In The Last Decade

Edward J. Lewis

5 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edward J. Lewis United Kingdom	5	223	150	77	49	46	5	360
Donna-Michelle Smith United Kingdom	9	151 0.7×	213 1.4×	100 1.3×	28 0.6×	34 0.7×	12	363
Elisabeth V. Schneider Germany	7	238 1.1×	172 1.1×	76 1.0×	67 1.4×	37 0.8×	8	409
Alexis de Haven Brandon United Kingdom	12	424 1.9×	179 1.2×	81 1.1×	28 0.6×	70 1.5×	22	595
Lora A. Tucker United States	13	326 1.5×	242 1.6×	84 1.1×	21 0.4×	61 1.3×	15	577
Jeff Kucharski United States	6	534 2.4×	216 1.4×	94 1.2×	42 0.9×	86 1.9×	10	656
Michael Grondine United States	8	421 1.9×	265 1.8×	67 0.9×	25 0.5×	39 0.8×	14	544
Martine B.W. Prinsen Netherlands	11	270 1.2×	151 1.0×	80 1.0×	29 0.6×	23 0.5×	19	456
Kerry A. Pickin United States	9	315 1.4×	187 1.2×	42 0.5×	22 0.4×	45 1.0×	11	456
Kazuhiro Ohara Japan	4	346 1.6×	138 0.9×	45 0.6×	53 1.1×	36 0.8×	6	407
Henrik Moebitz Switzerland	5	325 1.5×	119 0.8×	30 0.4×	58 1.2×	105 2.3×	8	441

Countries citing papers authored by Edward J. Lewis

Since Specialization

Citations

This map shows the geographic impact of Edward J. Lewis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward J. Lewis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward J. Lewis more than expected).

Fields of papers citing papers by Edward J. Lewis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward J. Lewis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward J. Lewis. The network helps show where Edward J. Lewis may publish in the future.

Co-authorship network of co-authors of Edward J. Lewis

This figure shows the co-authorship network connecting the top 25 collaborators of Edward J. Lewis. A scholar is included among the top collaborators of Edward J. Lewis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward J. Lewis. Edward J. Lewis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Ward, George A., Edward J. Lewis, Jong Sook Ahn, et al.. (2018). ASTX660, a Novel Non-peptidomimetic Antagonist of cIAP1/2 and XIAP, Potently Induces TNFα-Dependent Apoptosis in Cancer Cell Lines and Inhibits Tumor Growth. Molecular Cancer Therapeutics. 17(7). 1381–1391. 53 indexed citations

2.

Tamanini, Emiliano, Ildiko M. Buck, Gianni Chessari, et al.. (2017). Discovery of a Potent Nonpeptidomimetic, Small-Molecule Antagonist of Cellular Inhibitor of Apoptosis Protein 1 (cIAP1) and X-Linked Inhibitor of Apoptosis Protein (XIAP). Journal of Medicinal Chemistry. 60(11). 4611–4625. 57 indexed citations

3.

Chessari, Gianni, Ildiko M. Buck, James E. H. Day, et al.. (2015). Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Discovery of a Non-Alanine Lead Series with Dual Activity Against cIAP1 and XIAP. Journal of Medicinal Chemistry. 58(16). 6574–6588. 67 indexed citations

4.

Squires, Matthew, Laurence Cooke, Victoria Lock, et al.. (2010). AT7519, a Cyclin-Dependent Kinase Inhibitor, Exerts Its Effects by Transcriptional Inhibition in Leukemia Cell Lines and Patient Samples. Molecular Cancer Therapeutics. 9(4). 920–928. 49 indexed citations

5.

Squires, Matthew, Ruth E. Feltell, Nicola G. Wallis, et al.. (2009). Biological characterization of AT7519, a small-molecule inhibitor of cyclin-dependent kinases, in human tumor cell lines. Molecular Cancer Therapeutics. 8(2). 324–332. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact